dapsone has been researched along with minocycline in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (28.57) | 18.2507 |
| 2000's | 15 (35.71) | 29.6817 |
| 2010's | 15 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ala, J; Hall, JJ; Reeve, PA | 1 |
| Gelber, RH; Lalwani, AK; Tami, TA | 1 |
| Gradini, R; Lichter, MD; Solomon, LM; Welykyj, SE | 1 |
| Hironaga, M; Mochizuki, T; Watanabe, S | 1 |
| Chehl, SK; Gelber, RH; Murray, LP; Richard, V; Siu, P; Tsang, M | 1 |
| Powell, FC; Rogers, S; Wayte, JA | 1 |
| Gidoh, M; Saito, H | 1 |
| Cirioni, O; Giacometti, A; Scalise, G | 1 |
| Bhattacharya, SN; Jain, S; Kumar, S; Sehgal, VN | 1 |
| Gelber, RH | 1 |
| Chauhan, DS; Gupta, UD; Katoch, K; Katoch, VM; Natrajan, M; Sharma, RK; Sharma, VD; Singh, D; Singh, HB; Srivastava, K | 1 |
| Aramaki, J; Happle, R | 1 |
| Connolly, SM; DiCaudo, DJ | 1 |
| Igarashi, Y; Ishiguro, N; Kawashima, M; Okamoto, R; Shishido, E; Yamada, M | 1 |
| Abalos, RM; Balagon, MV; Cellona, RV; Dela Cruz, EC; Fajardo, TT; Tan, EV; Villahermosa, LG; Walsh, DS; Walsh, GP | 1 |
| Esaki, C; Ichiki, Y; Izumi, T; Kitajima, Y | 1 |
| Biswas, SK | 1 |
| Asahina, A; Minatani, Y; Mitsui, H; Tada, Y; Tamaki, K | 1 |
| Booth, AV; Kovich, OI | 1 |
| Carlson, JA; Kircher, K; Mazza, J; Tran, TA | 1 |
| Ozaki, M | 1 |
| Bigé, N; Gallien, S; Gervais, A; Kitzis, MD; Leport, C; Longuet, P | 1 |
| Fujimoto, M; Hashimoto, T; Ishiura, N; Nakashima, H; Tamaki, K; Watanabe, R; Yamamoto, AI | 1 |
| Hall, JM; Kahn, MA; Moreland, AA; Moschella, SL; Torske, KR | 1 |
| Ladizinski, B; Levis, WR; Spencer, TI | 1 |
| Chalmers, RJ; Reddick, CL; Singh, MN | 1 |
| Chang, SE; Choi, JH; Chung, WK; Kim, JK; Ko, JY; Lee, JH; Lee, MW; Moon, KC; Won, CH | 1 |
| Cunha, Mda G; Lockwood, DN | 1 |
| Levin, NA; Makredes, M; O'Donnell, P; Yang, S | 1 |
| Hashimoto, T; Ishii, N; Teye, K | 1 |
| Bajaj, S; Bose, SK; Sardana, K | 1 |
| McLarnon, JG | 1 |
3 review(s) available for dapsone and minocycline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Present status of studies on antileprosy drugs].
Topics: Animals; Clarithromycin; Dapsone; Drug Therapy, Combination; Humans; Immunologic Factors; Leprostatic Agents; Minocycline; Prothionamide; Quinolones; Rifampin; Rifamycins; Thalidomide | 1995 |
Consideration of a Pharmacological Combinatorial Approach to Inhibit Chronic Inflammation in Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Dapsone; Drug Therapy, Combination; Humans; Ibuprofen; Inflammation; Minocycline; Neuroprotective Agents; Thalidomide | 2019 |
1 trial(s) available for dapsone and minocycline
| Article | Year |
|---|---|
Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Minocycline; Ofloxacin; Rifampin | 2004 |
38 other study(ies) available for dapsone and minocycline
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Modification of multidrug treatment of leprosy in Vanuatu.
Topics: Aged; Dapsone; Drug Combinations; Ethionamide; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Minocycline; Vanuatu | 1992 |
Lepromatous leprosy: nasal manifestations and treatment with minocycline.
Topics: Adult; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Lepromatous; Male; Minocycline; Nose Diseases; Rifampin | 1992 |
Superficial granulomatous pyoderma.
Topics: Adult; Chronic Disease; Dapsone; Diagnosis, Differential; Granuloma; Humans; Male; Minocycline; Pyoderma; Recurrence; Skin Ulcer | 1991 |
Acute primary cutaneous nocardiosis.
Topics: Acute Disease; Child; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Minocycline; Nocardia Infections; Skin Diseases, Infectious | 1990 |
Activity of combinations of dapsone, rifampin, minocycline, clarithromycin, and sparfloxacin against M. leprae-infected mice.
Topics: Animals; Anti-Infective Agents; Clarithromycin; Dapsone; Drug Therapy, Combination; Female; Fluoroquinolones; Leprosy; Mice; Mice, Inbred BALB C; Minocycline; Quinolones; Rifampin | 1995 |
Pyoderma gangrenosum, erythema elevatum diutinum and IgA monoclonal gammopathy.
Topics: Adult; Dapsone; Drug Therapy, Combination; Erythema; Humans; Immunoglobulin A; Male; Minocycline; Monoclonal Gammopathy of Undetermined Significance; Prednisolone; Pyoderma Gangrenosum | 1995 |
In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Artemisinins; Atovaquone; Cryptosporidiosis; Cryptosporidium parvum; Dapsone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lactones; Macrolides; Minocycline; Naphthoquinones; Pyrimethamine; Sesquiterpenes | 1996 |
Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Drug Monitoring; Granuloma; Histiocytes; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Lymphocytes; Male; Minocycline; Ofloxacin; Recurrence; Rifampin | 1998 |
[New WHO recommendations for the treatment of leprosy].
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin; Skin | 1997 |
Another view of the therapy of leprosy.
Topics: Animals; Anti-Bacterial Agents; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Mice; Minocycline; Rifampin | 1998 |
Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline.
Topics: Adenosine Triphosphate; Biopsy; Clofazimine; Dapsone; DNA, Bacterial; Drug Evaluation; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Treatment Outcome | 1999 |
[Prurigo pigmentosa].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Dapsone; Diagnosis, Differential; Female; Humans; Hyperpigmentation; Incontinentia Pigmenti; Male; Middle Aged; Minocycline; Prurigo; Recurrence; Skin; Time Factors | 2001 |
Cutaneous drug reaction case reports: from the world literature.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Aged; Amlodipine; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Anticonvulsants; Antihypertensive Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; BCG Vaccine; Cefotetan; Cephamycins; Contrast Media; Cysteine; Dapsone; Diltiazem; Dipyrone; Docetaxel; Drug Eruptions; Echinacea; Enoxaparin; Female; Fructose; Glucans; Glucose; Gold Sodium Thiomalate; Humans; Ibuprofen; Icodextrin; Ioxaglic Acid; Male; Middle Aged; Minocycline; Paclitaxel; Pregnancy; Solvents; Taxoids; Topiramate; Triamcinolone; Trichloroethylene | 2001 |
Neutrophilic dermatosis (pustular vasculitis) of the dorsal hands: a report of 7 cases and review of the literature.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Female; Glucocorticoids; Hand Dermatoses; Humans; Middle Aged; Minocycline; Neutrophils; Prednisone; Recurrence; Suppuration; Treatment Outcome; Vasculitis | 2002 |
Ofuji's disease: a report on 20 patients with clinical and histopathologic analysis.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arm; Back; Dapsone; Facial Dermatoses; Female; Folliculitis; Foot; Humans; Immunohistochemistry; Indomethacin; Japan; Male; Mast Cells; Middle Aged; Minocycline; Prednisolone; Sulfamethoxazole; Thorax; Treatment Outcome | 2002 |
Monitoring of ELISA for anti-BP180 antibodies: clinical and therapeutic analysis of steroid-treated patients with bullous pemphigoid.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Autoantibodies; Autoantigens; Collagen Type XVII; Dapsone; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Humans; Male; Middle Aged; Minocycline; Non-Fibrillar Collagens; Pemphigoid, Bullous; Prednisolone | 2004 |
Chemotherapy of leprosy.
Topics: Anti-Bacterial Agents; Clofazimine; Dapsone; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Hypersensitivity; India; Leprosy; Minocycline; Nausea; Ofloxacin; Rifampin; Secondary Prevention; Tuberculosis; World Health Organization | 2004 |
Successful treatment of Pyoderma gangrenosum with potassium iodide.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dermatologic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Minocycline; Potassium Iodide; Prednisolone; Pyoderma Gangrenosum | 2006 |
Lepromatous leprosy.
Topics: Biopsy; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Lepromatous; Middle Aged; Minocycline; Skin | 2007 |
Otophyma: a case report and review of the literature of lymphedema (elephantiasis) of the ear.
Topics: Adrenal Cortex Hormones; Alcoholism; Anti-Infective Agents; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Dapsone; Doxycycline; Ear Deformities, Acquired; Elephantiasis; Fenofibrate; Fluoxetine; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Hypolipidemic Agents; Insecticides; Male; Middle Aged; Minocycline; Mite Infestations; Mood Disorders; Permethrin; Prednisone; Rosacea; Triamcinolone | 2008 |
[Trends in therapy for Hansen disease].
Topics: Dapsone; Humans; Japan; Leprosy; Minocycline; Plant Oils; Quinolones; Rifampin | 2009 |
Drug-to-drug interaction between dapsone and minocycline: an unusual cause of relapse of toxoplasmic encephalitis in an HIV-infected patient.
Topics: Adult; Dapsone; Drug Interactions; Encephalitis; HIV Infections; HIV-1; Humans; Male; Minocycline; Recurrence; Toxoplasma; Toxoplasmosis, Cerebral | 2009 |
Herpetiform pemphigus without anti-desmoglein 1/3 autoantibodies.
Topics: Aged; Autoantibodies; Carcinoma, Squamous Cell; Dapsone; Desmoglein 1; Desmoglein 3; Desmosomes; Eosinophils; Esophageal Neoplasms; Humans; Immunoglobulin A; Immunoglobulin G; Keratinocytes; Male; Minocycline; Pemphigus; Prednisolone | 2010 |
Clinical-pathological conference: case 3.
Topics: Adult; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Immunologic Deficiency Syndromes; Infections; Leishmaniasis; Leprostatic Agents; Leprosy, Multibacillary; Male; Minocycline; Mycobacterium leprae; Ofloxacin; Palate; Prednisone; Rifampin; Strongyloidiasis; Treatment Outcome | 2010 |
Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Hyperpigmentation; Leprostatic Agents; Leprosy; Minocycline; New York; Patient Preference; Rifampin | 2010 |
Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Comorbidity; Cyclosporine; Dapsone; Hidradenitis Suppurativa; Humans; Infliximab; Male; Methylprednisolone; Middle Aged; Minocycline; Prednisolone; Pyoderma Gangrenosum; Thalidomide; Treatment Outcome | 2010 |
Prurigo pigmentosa: clinicopathological study and analysis of 50 cases in Korea.
Topics: Adolescent; Adult; Dapsone; Diet; Female; Humans; Male; Middle Aged; Minocycline; Pigmentation Disorders; Prurigo; Republic of Korea; Young Adult | 2012 |
Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Patient Compliance; Rifampin; World Health Organization | 2012 |
A case of Hansen Disease presenting as tinea versicolor.
Topics: Clofazimine; Contraindications; Dapsone; Delayed Diagnosis; Diagnostic Errors; Humans; Hypesthesia; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Male; Minocycline; Mycobacterium leprae; Rifampin; Tinea Versicolor; Young Adult | 2013 |
Clinical and immunological studies of 49 cases of various types of intercellular IgA dermatosis and 13 cases of classical subcorneal pustular dermatosis examined at Kurume University.
Topics: Animals; Anti-Bacterial Agents; Autoimmune Diseases; Cohort Studies; Dapsone; Dermatologic Agents; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Direct; Humans; Immunoglobulin A; Male; Middle Aged; Minocycline; Skin Diseases, Vesiculobullous | 2017 |
Successful treatment of PAPA syndrome with minocycline, dapsone, deflazacort and methotrexate: a cost-effective therapy with a 2-year follow-up.
Topics: Acne Vulgaris; Anti-Inflammatory Agents; Arthritis, Infectious; Cost-Benefit Analysis; Dapsone; Dermatologic Agents; Drug Therapy, Combination; Humans; Methotrexate; Minocycline; Pregnenediones; Pyoderma Gangrenosum; Skin | 2019 |